Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions
Interventions
Sponsors
The First Affiliated Hospital, College of Medicine, Zhejiang University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years, diagnosed with CLL/SLL. 2. Indicate treatment according to the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) criteria. 3. No BTK inhibitor was used in the initial or previous treatment. 4. ECOG performance status score =3 months. 6. The patient or their legal representative has signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. A diagnosis or treatment of a malignant tumor other than CLL within the past year (including active central nervous system lymphoma); 2. Clinical evidence of Richter's transformation; 3. Participants cannot receive or plan to receive another investigational treatment during the study period; 4. Other conditions deemed unsuitable for participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Partial response rate;Stable disease rate;Disease progression rate;Progression free survival;Overall survival;Safety; | — |
Countries
China
Contacts
Public ContactWenjuan Yu
The First Affiliated Hospital of Zhejiang University Medical College
Outcome results
None listed